Cargando…
Inhibition of COX-2 signaling favors E. coli during urinary tract infection
BACKGROUND: To avoid the overuse of antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), acting via cyclooxygenase (COX) inhibition, have been used to reduce pain and as an alternative treatment for uncomplicated urinary tract infections (UTIs). However, clinical studies evaluating NSAIDs ve...
Autores principales: | Mohanty, Soumitra, Lindelauf, Ciska, White, John Kerr, Scheffschick, Andrea, Ehrenborg, Ewa, Demirel, Isak, Brauner, Hanna, Brauner, Annelie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496388/ https://www.ncbi.nlm.nih.gov/pubmed/37697284 http://dx.doi.org/10.1186/s12950-023-00356-9 |
Ejemplares similares
-
Metformin strengthens uroepithelial immunity against E. coli infection
por: Majhi, Rakesh Kumar, et al.
Publicado: (2021) -
Vitamin D strengthens the bladder epithelial barrier by inducing tight junction proteins during E. coli urinary tract infection
por: Mohanty, Soumitra, et al.
Publicado: (2020) -
Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder
por: Mohanty, Soumitra, et al.
Publicado: (2022) -
MV140 mucosal bacterial vaccine improves uropathogenic E. coli clearance in an experimental model of urinary tract infection
por: Saz-Leal, Paula, et al.
Publicado: (2023) -
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections
por: Lüthje, Petra, et al.
Publicado: (2016)